[Five-fraction radiotherapy for breast cancer]

M Dworczak; G Bielinyte; A Coutte; X Mirabel; É Lartigau; P Lemoine; S Rivera; D Pasquier

doi:10.1016/j.canrad.2023.07.004

[Five-fraction radiotherapy for breast cancer]

Cancer Radiother. 2023 Sep;27(6-7):531-534. doi: 10.1016/j.canrad.2023.07.004. Epub 2023 Aug 1.

[Article in French]

Authors

M Dworczak¹, G Bielinyte², A Coutte³, X Mirabel⁴, É Lartigau⁵, P Lemoine⁴, S Rivera⁶, D Pasquier⁵

Affiliations

¹ Département de radiothérapie, centre Oscar-Lambret, Lille, France. Electronic address: [email protected].
² Département de radiothérapie, institut Gustave-Roussy, Villejuif, France.
³ Département de radiothérapie, centre hospitalier universitaire d'Amiens Picardie, Amiens, France.
⁴ Département de radiothérapie, centre Oscar-Lambret, Lille, France.
⁵ Département de radiothérapie, centre Oscar-Lambret, Lille, France; Cristal UMR 9189, université de Lille, école Centrale de Lille, CNRS, Lille, France.
⁶ Département de radiothérapie, institut Gustave-Roussy, Villejuif, France; Laboratoire de radiothérapie moléculaire et d'innovation thérapeutique, université Paris-Saclay, U1030, Inserm, Villejuif, France.

PMID: 37537026
DOI: 10.1016/j.canrad.2023.07.004

Abstract

Extreme hypofractionation in adjuvant breast radiotherapy currently generates a lot of interest. We propose here a synthesis of hypofractionation trials and present the DESTHE COL and DESTHE GR projects, encouraged by the French National Cancer Institute (INCa), which experiment care pathways in order to deploy effective strategies to de-escalate the therapeutics and to reduce sequelae after cancer treatment.

Keywords: Breast cancer; Cancer du sein; De-escalation; Désescalade thérapeutique; Radiotherapy; Radiothérapie.

Publication types

English Abstract

MeSH terms

Breast Neoplasms* / radiotherapy
Female
Humans
Radiotherapy, Adjuvant